| 1999 |
Laminin gamma1 (LAMC1) is required for laminin trimer assembly; knockout of LAMC1 in mouse embryonic stem cells results in absence of basement membranes, disorganized extracellular deposits of collagen IV and perlecan, and failure of nidogen deposition. Secreted nidogen and truncated laminin alpha1 were not incorporated into ECM without gamma1, demonstrating that gamma1 is essential for polymerizing laminin and for organizing other basement membrane components. |
Homologous recombination knockout in mouse ES cells; embryoid body culture; immunofluorescence/ECM fractionation |
The Journal of cell biology |
High |
9885251
|
| 1999 |
Basement membranes are not required for formation of the first epithelium (trophectodermal) during embryogenesis, but LAMC1-dependent basement membranes become essential for extra-embryonic endoderm differentiation (parietal yolk sac formation); homozygous LAMC1-null embryos die at E5.5 due to failure of primitive endoderm to differentiate into visceral and parietal endoderm. |
LAMC1 knockout mouse; histological analysis of embryos at multiple developmental timepoints |
The Journal of cell biology |
High |
9885251 9917858
|
| 1997 |
Transcription factor Sp1 directly transactivates the LAMC1 promoter via GC-rich elements; Sp1 overexpression in normal hepatocytes increases laminin-gamma1 mRNA, and co-transfection of LAMC1 promoter fragments with Sp1 in Drosophila SL2 cells (which lack endogenous Sp1) confirmed direct Sp1-mediated activation. |
Gel-shift (EMSA), DNase I hypersensitivity mapping, Sp1 overexpression, co-transfection/reporter assay in SL2 cells, in situ hybridization |
The American journal of pathology |
High |
9403717
|
| 1996 |
Regulatory elements for LAMC1 expression in hepatocytes reside between -594 bp and -94 bp of the murine promoter, containing GC- and CTC-motifs; a ~60 kDa polypeptide binds the CTC-rich sequence and is implicated in transcriptional activation; the pattern of nuclear factor binding differs between freshly isolated hepatocytes and cultured hepatocytes/hepatoma cells, corresponding to LAMC1 transcriptional status. |
Transfection of deletion mutants, gel-shift assay, Southwestern analysis, affinity chromatography, actinomycin D/cycloheximide treatment |
The Biochemical journal |
Medium |
8611150
|
| 2013 |
A missense mutation in LAMC1 (encoding a NID1-binding partner) disrupts the NID1-LAMC1 protein interaction as shown by structural modeling of the complex; this interaction is required for normal cerebellar development, and its loss is associated with autosomal dominant Dandy-Walker malformation and occipital cephaloceles. |
Whole-exome sequencing, protein interaction network analysis, structural modeling of NID1-LAMC1 complex |
Human mutation |
Medium |
23674478
|
| 2014 |
miR-29s (miR-29a/b/c) directly target the 3'UTR of LAMC1 as shown by luciferase reporter assays; silencing LAMC1 inhibits prostate cancer cell migration and invasion, placing LAMC1 downstream of miR-29s in the focal adhesion pathway. |
Luciferase reporter assay, siRNA knockdown, Transwell migration/invasion assay |
International journal of oncology |
Medium |
24820027
|
| 2015 |
Androgen receptor (AR) directly binds the genomic loci of miR-22 and miR-29a (ChIP-seq), which in turn target LAMC1 (luciferase reporter), establishing an AR→miR-22/miR-29a→LAMC1 regulatory axis in prostate cancer; AR activity suppresses miR-22/29a, thereby disinhibiting LAMC1. |
ChIP-seq, microarray expression profiling, luciferase reporter assay, miRNA mimic transfection |
Molecular endocrinology |
Medium |
26052614
|
| 2019 |
LAMC1 promotes the Warburg effect in hepatocellular carcinoma cells by upregulating PKM2 expression through the PTEN/PI3K/AKT pathway; LAMC1 knockdown decreased glucose consumption, lactate production, GLUT1, and LDHA expression alongside increased PTEN and decreased AKT phosphorylation, and these effects were rescued by PKM2 overexpression or blocked by PI3K inhibition. |
siRNA knockdown, PI3K inhibitor (LY294002), Western blot, glucose/lactate measurement, cell viability assay |
Cancer biology & therapy |
Medium |
30755064
|
| 2021 |
TGFβ1 upregulates LAMC1 in esophageal squamous cell carcinoma cells via synergistic activation by SMAD4 and SP1; LAMC1 then promotes tumor cell proliferation and migration via AKT-NFκB-MMP9/14 signaling and stimulates CXCL1 secretion, which induces formation of inflammatory cancer-associated fibroblasts (iCAF) through CXCR2-pSTAT3 signaling. |
RNA microarray, ChIP, siRNA/overexpression, Transwell migration, ELISA, co-culture experiments |
Molecular oncology |
Medium |
34218518
|
| 2017 |
LAMC1 mRNA acts as a competing endogenous RNA (ceRNA) by sequestering miR-124 through two binding sites in its 3'UTR, thereby relieving miR-124-mediated repression of CD151 and promoting HCC cell migration and invasion in a miR-124-dependent manner. |
Luciferase reporter (3'UTR), miR-124 overexpression/inhibition, Western blot, Transwell migration/invasion assay, clinical tissue correlation |
IUBMB life |
Medium |
28524360
|
| 2023 |
NUDT21 knockdown causes 3'UTR shortening of LAMC1 via preferential usage of a proximal polyadenylation signal, removing miR-124/506 binding sites, thereby relieving miRNA repression and increasing LAMC1 protein levels; this LAMC1 upregulation drives glioma cell migration, as co-depletion of LAMC1 with NUDT21 abolishes the migratory phenotype. |
PAC-seq, qRT-PCR, Western blot, siRNA co-depletion, Transwell migration assay |
Journal of neuro-oncology |
Medium |
37389756
|
| 2024 |
Exogenous recombinant LAMC1 (rLAMC1) attenuates neuronal apoptosis after subarachnoid hemorrhage by activating the FAK/PI3K/AKT pathway, increasing Bcl-XL and Bcl-2 and decreasing Bax and cleaved caspase-3; the protective effects were abolished by FAK inhibitor Y15 and PI3K inhibitor LY294002, and LAMC1 knockdown worsened neurological outcomes. |
Rat SAH model, intranasal rLAMC1 administration, siRNA knockdown, pharmacological inhibitors (Y15, LY294002), Western blot, TUNEL staining, immunofluorescence, behavioral testing |
Experimental neurology |
Medium |
38609046
|
| 2022 |
LAMC1 secreted by gastric cancer cells in an autocrine manner promotes preadipocyte differentiation and rupture, releasing free fatty acids into the peritoneal microenvironment to form pre-metastatic niches; differentiated adipocyte-derived palmitic acid activates STAT3, which inhibits miR-193a-3p, and miR-193a-3p in turn post-translationally regulates LAMC1, forming a feedforward loop promoting peritoneal metastasis. |
Co-culture model, luciferase reporter, RNA immunoprecipitation (RIP), ChIP, single-molecular magnetic tweezers, immunohistochemistry, single-cell sequencing |
International journal of biological sciences |
Medium |
35541892
|
| 2024 |
LAMC1 overexpression in astrocytes/endothelial cells preserves blood-brain barrier integrity after intracerebral hemorrhage by inhibiting degradation of tight junction proteins ZO-1 and occludin; AAV-mediated LAMC1 overexpression in vivo reduced brain edema and improved neuromotor function. |
Mouse ICH model, AAV-mediated overexpression, Evans Blue extravasation, brain edema measurement, Western blot, neurobehavioral testing, multi-omics (TWAS/PWAS) + single-cell eQTL for gene identification |
Journal of advanced research |
Medium |
41534552
|
| 2006 |
A SNP (rs10911193) in the LAMC1 promoter disrupts a binding site for transcription factor NFIL3, which is co-expressed with LAMC1 in vaginal tissue; the rare T variant segregates with early-onset pelvic organ prolapse in a three-generation family, suggesting NFIL3-mediated regulation of LAMC1 expression is relevant to connective tissue integrity. |
Genome-wide linkage scan, SNP sequencing, RT-PCR for co-expression, transcription factor binding site analysis |
Human genetics |
Low |
17021862
|
| 2022 |
The LAMC1 intronic SNP rs3768617 shows allele-specific binding of transcription factor GFI1B to the risk allele 'G' but not the protective allele 'A', validated by EMSA and ChIP assay; GFI1B expression is reduced ~0.63-fold in Fuchs endothelial corneal dystrophy (FECD)-affected corneal endothelium, linking GFI1B-dependent LAMC1 regulation to FECD pathogenesis. |
EMSA, ChIP assay, luciferase reporter assay, immunofluorescence, genetic association study |
Gene |
Medium |
35031421
|
| 2024 |
LAMC1 promotes osteogenic differentiation and inhibits adipogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs); Lamc1 knockdown inhibited both adipogenic and osteogenic differentiation, and cell communication analysis identified two receptors interacting with LAMC1 in this context. |
Single-cell RNA-seq analysis, qPCR validation, siRNA knockdown, transcriptomic dataset analysis |
Scientific reports |
Low |
39179716
|
| 2024 |
LAMC1 knockdown decreased platelet-endothelium interaction in hyperglycemic HUVECs and did not potentiate the effects of PDI inhibitors, placing LAMC1 downstream of endothelial pecPDI in a pathway regulating platelet adhesion; LAMC1 was identified as one of 8 proteins secreted in a PDI-dependent manner by hyperglycemic endothelial cells. |
Secretomics (proteomics), siRNA knockdown, immunofluorescence, transendothelial electrical resistance, atomic force microscopy, Amplex Red H2O2 assay |
Journal of thrombosis and haemostasis |
Low |
39128656
|
| 2025 |
LAMC1 is a stable ECM component in fin fold matrix but more dynamic (higher FRAP recovery) in myoseptal matrix of developing zebrafish, demonstrating tissue context-dependent stability of LAMC1 within basement membranes in vivo. |
CRISPR knock-in fluorescent tagging of endogenous Lamc1, live imaging, FRAP analysis in zebrafish |
bioRxivpreprint |
Medium |
|